Investment analysts and portfolio managers look into their crystal balls to predict the best-performing stocks for the year ahead.
The total raised ‘exceeded the company’s expectations’ but fell short of original targets.
Handover from Fletcher Building ends 10-year construction saga.
The Australian-owned bank guides the start of New Zealand’s economic recovery as customers refix on to lower interest rates.
The listed medicinal cannabis company’s ongoing cash operating losses means ongoing growth can’t be maintained without additional capital to fund required inventory.
InfraKiwi would be natural buyer of council and government assets, says Sam Stubbs.
Fund manager Allan Gray follows through on threat to vote against the re-election of directors as shareholder questions ‘selective leaking’ of news to Australian journalists.
The new largely automated Māngere site is touted as the most advanced life sciences and healthcare logistics facility in NZ.
The supermarket group blamed industrial action and supply chain disruptions for its 2025 performance, and said it was targeting ‘mid to high percentage’ ebit growth.
‘Significant changes’ required if Me Today resolutions don’t pass at its AGM, directors say.
